Recent advances in the medical research field have expanded into the use of microfluidics devices, offering innovative solutions for healthcare challenges. Precise control over fluid manipulation at small scales and significant sample volume reduction are just some of the different benefits introduced by these advanced microdevices. In the framework of the European project ANGIE (MAgnetically steerable wireless Nanodevices for the tarGeted delivery of therapeutic agents in any vascular rEgion of the body), focus on exploring the potential use of mobile microrobotic platforms for clot removal. The use of microfluidic devices is key to control the generation of blood clots in confined spaces.